D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Donaldson
DCI
$10.8B
| $11.9M | 0.01% |
204,323
-2,048
| -1% | -$122K |
|
|
EXPR
1152
DELISTED
Express, Inc.
EXPR
| $11.8M | 0.01% |
147,378
+145,407
| +7,377% | +$9.12M |
|
1153
Realty Income
O
$61.2B
| $11.8M | 0.01% |
192,017
-309,804
| -62% | -$18.4M |
|
1154
SEI Investments
SEIC
$12.2B
| $11.8M | 0.01% |
193,441
+31,855
| +20% | +$1.87M |
|
1155
Lattice Semiconductor
LSCC
$16.8B
| $11.8M | 0.01% |
261,746
+126,692
| +94% | +$5.62M |
|
1156
Denali Therapeutics
DNLI
$3.81B
| $11.8M | 0.01% |
206,162
+126,802
| +160% | +$8.49M |
|
1157
Gildan
GIL
$9.36B
| $11.7M | 0.01% |
381,280
-144,920
| -28% | -$4.13M |
|
|
FTCH
1158
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $11.7M | 0.01% |
220,000
-62,700
| -22% | -$3.84M |
|
1159
Arcosa
ACA
$7.13B
| $11.7M | 0.01% |
179,082
-61,358
| -26% | -$3.77M |
|
|
CCXI
1160
DELISTED
ChemoCentryx, Inc.
CCXI
| $11.6M | 0.01% |
227,273
-469,821
| -67% | -$28.3M |
|
1161
BP
BP
$109B
| $11.6M | 0.01% |
478,197
+103,471
| +28% | +$2.49M |
|
1162
Ashland
ASH
$3.04B
| $11.6M | 0.01% |
130,993
-75,525
| -37% | -$6.51M |
|
1163
Cars.com
CARS
$664M
| $11.6M | 0.01% |
896,574
-377,117
| -30% | -$4.94M |
|
1164
CALL
Lowe's Companies
LOW
$119B
| $11.6M | 0.01% |
60,800
+5,400
| +10% | +$927K |
|
1165
MacroGenics
MGNX
$256M
| $11.5M | 0.01% |
362,417
-204,987
| -36% | -$4.98M |
|
|
PRPB
1166
DELISTED
CC Neuberger Principal Holdings II Class A Ordinary Shares
PRPB
| $11.4M | 0.01% |
1,160,528
+310,528
| +37% | +$3.25M |
|
|
EQC
1167
DELISTED
Equity Commonwealth
EQC
| $11.4M | 0.01% |
411,048
-287,152
| -41% | -$8.11M |
|
1168
PUT
Credit Acceptance
CACC
$5.82B
| $11.4M | 0.01% |
31,700
+1,700
| +6% | +$616K |
|
1169
LiveRamp
RAMP
$2.3B
| $11.4M | 0.01% |
219,757
+188,272
| +598% | +$12.8M |
|
1170
Broadridge
BR
$17.7B
| $11.4M | 0.01% |
74,294
+55,984
| +306% | +$8.27M |
|
1171
AMC Global Media
AMCX
$451M
| $11.4M | 0.01% |
+213,639
| New | +$11.7M |
|
1172
CALL
Zebra Technologies
ZBRA
$12.7B
| $11.4M | 0.01% |
23,400
+9,700
| +71% | +$4.33M |
|
|
ARCH
1173
DELISTED
Arch Resources, Inc.
ARCH
| $11.4M | 0.01% |
272,853
+128,289
| +89% | +$6.18M |
|
1174
Vanda Pharmaceuticals
VNDA
$316M
| $11.3M | 0.01% |
754,429
+341,970
| +83% | +$5.54M |
|
1175
CALL
Appian
APPN
$1.88B
| $11.3M | 0.01% |
85,200
+50,000
| +142% | +$8.85M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.